Advertisement
Screener

Summit Therapeutics Inc. (SMMT) Pre-Tax Margin

Summit Therapeutics Inc. (SMMT) Pre-Tax Margin

  • 2021-12-31: Pre-Tax Margin -10796.41%.
  • 2021-09-30: Pre-Tax Margin -1497.25%.
  • 2021-06-30: Pre-Tax Margin -42835.09%.
  • 2021-03-31: Pre-Tax Margin -9108.33%.

Complete source-backed pre-tax margin history.

Available history
2019-01-31 to 2022-12-31
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2021-12-31-10796.41%
2021-09-30-1497.25%
2021-06-30-42835.09%
2021-03-31-9108.33%
2020-12-31-7330.81%
2020-09-30-9833.70%
2020-06-30-9100.00%
2020-03-31-1876.23%
2019-09-30-4233.11%

Annual Pre-Tax Margin

DatePre-Tax Margin
2022-12-31-11174.75%
2021-12-31-4897.84%
2020-12-31-6152.33%
2019-12-31-3915.34%
2019-01-3115.91%

Similar stocks

Stock NameCountryMarket CapPE Ratio
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52